cardiometabolic clinics glp-1 therapy near me Heart transplantation in the Era: Time to catch up? Invited commentary for “The association between glucagon-like peptide 1 receptor agonist and outcomes after heart transplant” Improving prevention strategies for cardiometabolic

Klow Wolverine (4-in-1) adds KPV (NF-B inhibition) to the Glow Blend, incorporating inflammation control into the protocol

SWItching on epidermal cell fate

Maternal obesity during lactation may protect offspring from high fat diet-induced metabolic dysfunction

Drink at least 23 liters of water daily unless your provider advises otherwise

KPV directly addresses the NF-kB dysregulation and cytokine overproduction that define psoriasis at the molecular level

The US Food and Drug Administration (FDA) gave the green light on Wednesday to a new oral weight-loss medication developed by the Indianapolis-based pharmaceutical company Eli Lilly